Immunophenotyping of Acute Lymphoblastic Leukemia

Area of Science:

• Hematology
• Immunology
• Clinical Diagnostics

Background:

• Immunophenotyping by flow cytometry is crucial for diagnosing acute lymphoblastic leukemia (ALL).
• Detecting minimal residual disease (MRD) post-therapy is a significant prognostic factor for ALL patients.
• Accurate immunophenotypic analysis guides individualized treatment strategies.

Purpose of the Study:

• To detail laboratory methods for immunophenotyping in acute lymphoblastic leukemia.
• To describe techniques for characterizing lymphoblasts at diagnosis.
• To outline procedures for detecting minimal residual disease after ALL treatment.

Main Methods:

• Utilizing flow cytometry for immunophenotypic analysis of peripheral blood and bone marrow samples.
• Employing specific antibody combinations for cell-surface and intracellular protein labeling.
• Implementing standardized procedures for sample preparation and data analysis.

Main Results:

• Established antibody panels for reliable diagnosis of ALL.
• Developed sensitive methods for detecting rare leukemic lymphoblasts, indicating MRD.
• Provided a framework for analyzing complex immunophenotypic data.

Conclusions:

• Laboratory methods for immunophenotyping are essential for ALL diagnosis and MRD detection.
• Accurate MRD assessment via flow cytometry enables personalized treatment adjustments.
• These standardized techniques improve the management and prognosis of acute lymphoblastic leukemia patients.